Edward Sheldon

Edward grew up in Melbourne, Australia and developed a strong passion for investing during his university years. 15 years later and now based in London, Edward mainly invests in dividend growth stocks for the long term, however, he has been known to be tempted by the occasional small-cap opportunity. As well as writing for The Motley Fool, Edward also writes about dividend investing for Edward holds a Commerce degree from the University of Melbourne and is a CFA charterholder.

2 FTSE 100 stocks forecast to grow over 10% this year

Edward Sheldon looks at two FTSE 100 (INDEXFTSE:UKX) stocks that are set to power ahead and examines the investment case. More »

Just Eat plc isn’t the only FTSE 250 stock expected to deliver blockbuster growth

Edward Sheldon profiles a FTSE 250 (INDEXFTSE:MCX) stock that has outperformed Just Eat plc (LON:JE) over the last three years. More »

Why I’m not buying shares in Sirius Minerals plc just yet

Edward Sheldon explains why he isn't buying into the Sirius Minerals plc (LON: SXX) story just yet. More »

Are these the best FTSE 250 dividend growth stocks right now?

Edward Sheldon examines two FTSE 250 (INDEXFTSE:MCX) stocks generating unbelievable dividend growth. More »

Two small-cap dividend stars I’d buy to supercharge my portfolio

Edward Sheldon looks at two smaller companies capable of generating capital growth and paying dividends. More »

Why I’m not buying BT Group plc for its 5.6% dividend yield

BT Group plc (LON: BT.A) shares currently have a dividend yield of 5.6%. Edward Sheldon explains why he won't be buying them. More »

A three-point plan to retiring with a million

Think millionaire status is out of reach? Think again. More »

Why I’d buy this unloved 4% dividend stock over ASOS plc

ASOS plc (LON: ASOS) currently trades on a P/E ratio of almost 80. Is this retailer a better buy? More »

Why this growth stock should be a better buy than Boohoo.Com plc

Shares in Boohoo.Com (LON: BOO) trade at a sky-high valuation. Is this online retailer a better pick? More »

One attractive growth stock I’d buy ahead of Purplebricks Group plc

Shares in Purplebricks Group plc (LON: PURP) are up 240% since listing but Edward Sheldon believes he may have found a less risky small-cap... More »

Why this small-cap stock could be the UK’s most exciting investment opportunity right now

Edward Sheldon identifies a fast-growing small-cap biotech stock that he believes has considerable potential. More »

Is this Neil Woodford dividend stock the bargain of the year?

Edward Sheldon looks at two cheap dividend stocks Neil Woodford owns in his Income Focus fund. More »

Will Tesco plc pay its shareholders a dividend this year?

Edward Sheldon looks at whether Tesco plc (LON: TSCO) will finally pay its shareholders a dividend, after cutting its payout several years ago. More »

2 FTSE 250 growth stocks I would buy right now

Edward Sheldon looks at two exciting growth stock opportunities within the FTSE 250 (INDEXFTSE:MCX) index. More »

Why Monarch Airlines’ demise could boost demand for these two growth stocks

Monarch Airlines has today ceased trading. Could these two stocks benefit as a result? More »

2 FTSE 100 growth and dividend stocks I’d buy in October

Edward Sheldon looks at two FTSE 100 (INDEXFTSE:UKX) stocks that he believes offer potential for both capital growth and dividends. More »

This dividend growth stock is trading at an unbelievable valuation

Edward Sheldon looks at a technology focused small-cap dividend stock trading on a P/E of 8. More »

Neil Woodford just bought a small-cap stock you’ve likely never heard of

Neil Woodford just bought a £63m small-cap stock for his Income Focus portfolio. Was that a sensible move? More »

Will Israel-based Taptica International plc suffer the same fate as Telit Communications plc?

Telit Communications plc (LON:TCM) is down 50% since May. Could Taptica International plc's (LON: TAP) shares plummet further too? More »

Why I’d buy GlaxoSmithKline plc for its 5%+ dividend yield today

Edward Sheldon explains why he sees appeal in GlaxoSmithKline plc's (LON:GSK) 5.4% dividend yield. More »